Literature DB >> 27566023

Lower-extremity lymphedema following management for endometrial and cervical cancer.

Alberto A Mendivil1, Mark A Rettenmaier1, Lisa N Abaid1, John V Brown1, John P Micha1, Katrina L Lopez2, Bram H Goldstein3.   

Abstract

BACKGROUND: Despite the alleged benefits conferred by a lymphadenectomy in the management of gynecologic malignancies, there are concerns regarding the development of postoperative lower-extremity lymphedema. The purpose of this study was to identify the incidence of lymphedema and associated risk factors in accordance with surgical staging during the management of endometrial and cervical cancer.
METHOD: We conducted a 5-year review of all endometrial and cervical cancer patients who underwent a lymphadenectomy. The subjects' demographics, medical co-morbidities, diagnosis, surgical treatment, inclusion of adjuvant radiotherapy and incidence of lower-extremity lymphedema were noted.
RESULTS: We identified 165 (135 endometrial cancer and 30 cervical cancer) subjects. Positive pelvic and para-aortic lymph nodes were present in 21 (12.7%) and 10 patients (6.1%), respectively. In the entire population, 6 (3.6% incidence) subjects developed post-operative lymphedema. Supplementary analyses revealed that a BMI >35 kg/m(2) and possessing numerous (≥3) co-morbidities significantly correlated with the manifestation of lower-extremity lymphedema.
CONCLUSION: In the current investigation, we observed a reasonably low, overall incidence of postoperative lower-extremity lymphedema. Nevertheless, when evaluating the potential for lymphedema in patients for whom a lymphadenectomy is indicated, specific risk factors should be considered in an effort to attenuate the development of this morbid condition.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Endometrial cancer; Gynecologic surgery; Lymphadenectomy; Lymphedema

Mesh:

Year:  2016        PMID: 27566023     DOI: 10.1016/j.suronc.2016.05.015

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  6 in total

1.  Successful management of persistent lower extremity lymphedema with suction-assisted lipectomy.

Authors:  John P Micha; Dung H Nguyen; Bram H Goldstein
Journal:  Gynecol Oncol Rep       Date:  2017-12-19

2.  Lower Extremity Lymphedema in Gynecologic Cancer Patients: Propensity Score Matching Analysis of External Beam Radiation versus Brachytherapy.

Authors:  Won Ick Chang; Hyun-Cheol Kang; Hong-Gyun Wu; Hak Jae Kim; Seung Hyuck Jeon; Maria Lee; Hee Seung Kim; Hyun Hoon Chung; Jae Weon Kim; Noh Hyun Park; Yong Sang Song; Kwan-Sik Seo
Journal:  Cancers (Basel)       Date:  2019-09-30       Impact factor: 6.639

3.  Progressive resistance exercise training to prevent lower-limb lymphedema after cervical cancer surgery: A feasibility study.

Authors:  Jiajia Zhang; Xingzhu Ju; Zheng Feng; Xiaoju Zhang; Jin Li
Journal:  Asia Pac J Oncol Nurs       Date:  2021-12-25

4.  Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis.

Authors:  Hongyuan Hu; Mingru Fu; Xiujin Huang; Ju Huang; Jinniao Gao
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

5.  Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment.

Authors:  Teruyo Kunitake; Tatsuyuki Kakuma; Kimio Ushijima
Journal:  Int J Clin Oncol       Date:  2020-01-06       Impact factor: 3.402

6.  Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients.

Authors:  David Cibula; Martina Borčinová; Simone Marnitz; Jiří Jarkovský; Jaroslav Klát; Radovan Pilka; Aureli Torné; Ignacio Zapardiel; Almerinda Petiz; Laura Lay; Borek Sehnal; Jordi Ponce; Michal Felsinger; Octavio Arencibia-Sánchez; Peter Kaščák; Kamil Zalewski; Jiri Presl; Alicia Palop-Moscardó; Solveig Tingulstad; Ignace Vergote; Mikuláš Redecha; Filip Frühauf; Christhardt Köhler; Roman Kocián
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.